Pediatric Labeling Would Not Block Generic Approval - House Exclusivity Bill
Executive Summary
A generic drug would not have to include pediatric information in labeling in order to be approved under the pediatric exclusivity reauthorization bill passed by the House Commerce Committee.
You may also be interested in...
House Ped. Exclusivity Generic Approval Provision Would Save $67 Mil. – CBO
A provision in the House pediatric exclusivity legislation to approve generic applications despite lacking the innovators' pediatric labeling would reduce federal spending by $67 mil. over 2002-2006
House Ped. Exclusivity Generic Approval Provision Would Save $67 Mil. – CBO
A provision in the House pediatric exclusivity legislation to approve generic applications despite lacking the innovators' pediatric labeling would reduce federal spending by $67 mil. over 2002-2006
Pediatric Bill Toll-Free Adverse Event Hotline Is Of Concern To Pharmacy
The retail pharmacy trade associations are urging the House leadership to delete language creating an adverse event reporting hotline from the pediatric exclusivity bill